ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions

Peng, Ying-Long; Wang, Zi-Yan; Zhong, Ri-Wei; Mei, Shi-Qi; Liu, Jia-Qi; Tang, Li-Bo; Guo, Zhi; Ren, Zi-Rui; Wu, Lv; Deng, Yu; Chen, Zhi-Hong; Zhou, Qing; Xu, Chong-Rui*广东省人民医院; 广州医学院; 南方医科大学; 1
Cancers2024-1DOI: 10.3390/cancers16020304
12阅读
引用收藏
分享

摘要

Background: COVID-19 has been ravaging the globe for more than three years. Due to systemic immunosuppression of anti-tumor therapy, application of chemotherapy and adverse effects of surgery, the short- and long-term prognosis of cancer patients to COVID-19 are of significant concern. Method: This research included three parts of data. The first part of the data came from the public database that covered Veneto residents. The second part of the data included participants in Guangzhou. The third part of the data was used for MR analysis. We assessed the associations by logistic, linear or Cox regression when appropriate. Result: Lung cancer patients with COVID-19 had shorter progression-free survival (PFS) after COVID-19 (Model II: HR: 3.28, 95% CI: 1.6 similar to 6.72; Model III: HR: 3.39, 95% CI: 1.45 similar to 7.95), compared with lung cancer patients without COVID-19. Targeted therapy patients recovered from SARS-CoV-2 infection more quickly (Model I: ss: -0.58, 95% CI: -0.75 similar to-0.41; Model II: ss: -0.59, 95% CI: -0.76 similar to-0.41; Model III: ss: -0.57; 95% CI: -0.75 similar to-0.40). Conclusions: PFS in lung cancer patients is shortened by COVID-19. The outcome of COVID-19 in lung cancer patients was not significantly different from that of the healthy population. In lung cancer patients, targeted therapy patients had a better outcome of COVID-19, while chemotherapy patients had the worst.

学科与关键词

关键词
COVID-19lung cancerPFSSARS-CoV-2targeted therapy
相关
加载中…
  • High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
    Wang, Qianqian; Li, Liangyu; Qu, Tianyu; Li, Jie; Wu, Lingxiang; Li, Kening; Wang, Ziyu; Zhu, Mengyan; Huang, Bin; Wu, Wei; Wu, Min; Ding, Rong; Zhang, Zhihong; Wang, Qianghu; Xia, Xinyi*; Li, Pengping*; Zhang, Zhi; Guo, Renhua*Frontiers in Oncology, 2021, 11: 644575.被引 11
  • New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019
    Zhang, Chao; Wu, Yi-Long; Zhong, Wen-Zhao*Journal of Thoracic Oncology, 2022, 17(5): 588-591.被引 1
  • Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis
    Liu, Chao; Wang, Kai; Li, Luyuan; Lv, Qingquan; Liu, Yumei; Hu, Tian; Trent, Jonathan C.*; Sun, Bing*; Hu, Qinyong*American Journal of Cancer Research, 2021, 12(12): 3558-3565.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2024-01
卷期
第 16 卷, 第 2 期
页码
304
DOI
10.3390/cancers16020304
成果收录
SCIE
资助标注
National Natural Science Foundation of China

作者

  • P

    Peng, Ying-Long (第一作者)

    guangdong prov peoples hosp · southern med univ

  • W

    Wang, Zi-Yan

    1 · guangzhou med univ

查看全部 13 位作者收起作者
  • Z

    Zhong, Ri-Wei

    guangdong prov peoples hosp · southern med univ

  • M

    Mei, Shi-Qi

    guangdong prov peoples hosp · southern med univ

  • L

    Liu, Jia-Qi

    guangdong prov peoples hosp · southern med univ

  • T

    Tang, Li-Bo

    guangdong prov peoples hosp · southern med univ

  • G

    Guo, Zhi

    guangdong prov peoples hosp · southern med univ

  • R

    Ren, Zi-Rui

    guangdong prov peoples hosp · southern med univ

  • W

    Wu, Lv

    guangdong prov peoples hosp · southern med univ

  • D

    Deng, Yu

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Zhi-Hong

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhou, Qing

    guangdong prov peoples hosp · southern med univ

  • X

    Xu, Chong-Rui (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417